-transparent.png){kind=logo}
The Authors have studied the effects of Norethisterone enantate given i.m. every one or two months to 75 patients complaining of climacteric syndrome either spontaneous or induced surgically. An overall evaluation of the effectiveness of the treatment allowed the conclusion that with both timing of administration it is possible to obtain in the majority of patients (80%) a very good control of the climacteric symptoms with negligible side effects. A more careful clinical and laboratory evaluation has shown a fast regression of the symptoms already after one month of drug administration. Therefore norethisterone enantate may be considered an effective therapeutic alternative to estrogens and androgens in the management of the climacteric syndrome.
L De Cecco, and
P Rossato, and
E Rainer
September 1995,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
L De Cecco, and
P Rossato, and
E Rainer
January 1978,
La Prensa medica mexicana,
L De Cecco, and
P Rossato, and
E Rainer
June 1990,
Journal of the Egyptian Society of Parasitology,
L De Cecco, and
P Rossato, and
E Rainer
June 2018,
Journal of clinical pharmacology,
L De Cecco, and
P Rossato, and
E Rainer
October 2009,
Contraception,
L De Cecco, and
P Rossato, and
E Rainer
March 1982,
Obstetrics and gynecology,
L De Cecco, and
P Rossato, and
E Rainer
January 1969,
Anales del Programa Academico de Medicina,
L De Cecco, and
P Rossato, and
E Rainer
August 1975,
The Australasian journal of dermatology,
L De Cecco, and
P Rossato, and
E Rainer
July 1988,
Ceskoslovenska gynekologie,
L De Cecco, and
P Rossato, and
E Rainer
July 1986,
British medical journal (Clinical research ed.),
